Current status of porcine islet xenotransplantation
- 6 August 2020
- journal article
- review article
- Published by Wolters Kluwer Health in Current Opinion in Organ Transplantation
- Vol. 25 (5) , 449-456
Abstract
Purpose of review: Human islet transplantation has proven to be a highly effective treatment for patients with labile type 1 diabetes mellitus, which can free patients from daily glucose monitoring and insulin injections. However, the shortage of islet donors limits its’ broad application. Porcine islet xenotransplantation presents a solution to the donor shortage and recent advances in genetic modification and immunosuppressive regimens provide renewed enthusiasm for the potential of this treatment. Recent findings: Advances in genetic editing technology are leading to multigene modified porcine islet donors with alterations in expression of known xenoantigens, modifications of their complement and coagulation systems, and modifications to gain improved immunological compatibility. Recent NHP-based trials of costimulation blockade using CD154 blockade show promising improvements in islet survival, whereas results targeting CD40 are less consistent. Furthermore, trials using IL-6 receptor antagonism have yet to demonstrate improvement in glucose control and suffer from poor graft revascularization. Summary: This review will detail the current status of islet xenotransplantation as a potential treatment for type I diabetes mellitus, focusing on recent advances in porcine xenogeneic islet production, assessment in nonhuman primate preclinical models, the outcome of human clinical trials and review barriers to translation of xenoislets to the clinic.Keywords
This publication has 70 references indexed in Scilit:
- Infection Barriers to Successful Xenotransplantation Focusing on Porcine Endogenous RetrovirusesClinical Microbiology Reviews, 2012
- The Importance of Tissue Factor Expression by Porcine NICC in Triggering IBMIR in the Xenograft SettingTransplantation, 2011
- Long-term follow-up of patients with type 1 diabetes transplanted with neonatal pig isletsClinical and Experimental Immunology, 2010
- Complement regulation in the GalT KO eraXenotransplantation, 2010
- Long-Term Controlled Normoglycemia in Diabetic Non-Human Primates After Transplantation with hCD46 Transgenic Porcine IsletsAmerican Journal of Transplantation, 2009
- Translating costimulation blockade to the clinic: lessons learned from three pathwaysImmunological Reviews, 2009
- Reduction of Early Graft Loss After Intraportal Porcine Islet Transplantation in MonkeysTransplantation, 2007
- Correlation between β cell mass and glycemic control in type 1 diabetic recipients of islet cell graftProceedings of the National Academy of Sciences, 2006
- Reversal of diabetes in non‐immunosuppressed rhesus macaques by intraportal porcine islet xenografts precedes acute cellular rejectionXenotransplantation, 2004
- BIOSYNTHETIC HUMAN INSULIN IN THE TREATMENT OF DIABETESThe Lancet, 1982